How I manage frontline transplant-eligible multiple myeloma in Italy

The treatment of transplant-eligible multiple myeloma patients in Italy consists in an induction phase based on bortezomib plus thalidomide plus dexamethasone (VTd), followed by a single or tandem autologous stem cell transplantation (ASCT), followed by lenalidomide maintenance. This approach offers...

Descripción completa

Detalles Bibliográficos
Autores principales: Montefusco, Vittorio, Martinelli, Giovanni, Cerchione, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2020
Materias:
How to manage - Multiple Myeloma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520856/
https://www.ncbi.nlm.nih.gov/pubmed/33042503
http://dx.doi.org/10.4081/hr.2020.8954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520856/
https://www.ncbi.nlm.nih.gov/pubmed/33042503
http://dx.doi.org/10.4081/hr.2020.8954

Ejemplares similares